Viewing Study NCT02332902


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-26 @ 3:15 AM
Study NCT ID: NCT02332902
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Sponsor: The University of Texas Health Science Center, Houston
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HSC-MS-14-0758
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View